Sharon Walsh, PhD

University of Kentucky

Disclosure(s): Astra Zeneca: Advisor/Consultant; Braeburn Pharmaceuticals: Advisor/Consultant; Cerevel Therapeutics: Advisor/Consultant; Lundbeck: Advisor/Consultant; Opiant Pharmaceuticals: Advisor/Consultant

Poster(s):

• (P-107) Serious Injection-Related Infections in Hospitalized Adults with Opioid Use Disorder Enrolled in an Ongoing Randomized Clinical Trial: A Focus on Staphylococcus aureus
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT